cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Avidity Biosciences Inc
9 own
9 watching
Current Price
$46.28
$1.16
(2.57%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
841.97M
52-Week High
52-Week High
47.05000
52-Week Low
52-Week Low
4.82500
Average Volume
Average Volume
1.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
-12.91379688
iconMarket Capitalization841.97M
icon52-Week High47.05000
icon52-Week Low4.82500
iconAverage Volume1.35M
iconDividend Yield--
iconP/E Ratio-12.91379688
What does the Avidity Biosciences Inc do?
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company s lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Read More
How much money does Avidity Biosciences Inc make?
News & Events about Avidity Biosciences Inc.
PR Newswire
1 year ago
Avidity Biosciences to Participate in Upcoming Investor Conference Avidity Biosciences to Participate in Upcoming Investor Conference PR Newswire SAN DIEGO, June 29, 2023 SAN DIEGO, June 29, 2023 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to...
PR Newswire
1 year ago
Avidity Biosciences Joins with Patients, Caregivers and Healthcare Providers Globally to Support World Facioscapulohumeral Muscular Dystrophy (FSHD) Day Avidity Biosciences Joins with Patients, Caregivers and Healthcare Providers Globally to Support World Facioscapulohumeral Muscular Dystrophy...
Globe Newswire
1 year ago
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (Avidity or the Company) (NASDAQ: RNA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
1 year ago
Avidity Biosciences Granted FDA Fast Track Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy Mutations Amenable to Exon 44 Skipping Avidity Biosciences Granted FDA Fast Track Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy Mutations Amenable to Exon 44...
Globe Newswire
1 year ago
ATLANTA, April 20, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Avidity Biosciences, Inc. (Avidityor the Company) (NASDAQ: RNA) complied with federal securities laws. On March 30, 2023, Avidity provided an update on its product that is on a partial clinical hold for new ...
Frequently Asked Questions
Frequently Asked Questions
What is Avidity Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Avidity Biosciences Inc shares?
plus_minus_icon
How can I buy Avidity Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Avidity Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Avidity Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Avidity Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Avidity Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Avidity Biosciences Inc?
plus_minus_icon
What percentage is Avidity Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Avidity Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$46.28
$1.16
(2.57%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00